NCT02431936View on ClinicalTrials.gov

Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 16, 2019

Study Completion Date

April 16, 2019

Conditions
HypertensionStress, PsychologicalBlood Pressure
Interventions
DRUG

Prazosin

Double blind placebo controlled cross over trial to determine effectiveness of alpha adrenergic blocker in reducing sodium retention during stress.

DRUG

Placebo

Sugar pill made to look identical to Prazosin intervention.

Trial Locations (1)

30912

Augusta University, Augusta

All Listed Sponsors
collaborator

The University of Texas at Arlington

OTHER

lead

Augusta University

OTHER

NCT02431936 - Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress | Biotech Hunter | Biotech Hunter